ENHANCED T-CELL PROLIFERATION AND INCREASED RESPONDER FREQUENCY FOLLOWING DELIVERY OF ANTIGEN TO THE ANTIGEN-PRESENTING CELL - B-CELL DEPENDENCY AND USE IN DETECTION OF AUTOREACTIVE T-CELLS
Ej. Stevens et M. Peakman, ENHANCED T-CELL PROLIFERATION AND INCREASED RESPONDER FREQUENCY FOLLOWING DELIVERY OF ANTIGEN TO THE ANTIGEN-PRESENTING CELL - B-CELL DEPENDENCY AND USE IN DETECTION OF AUTOREACTIVE T-CELLS, Journal of immunological methods, 215(1-2), 1998, pp. 59-70
Reported frequencies of peripheral blood autoantigen-specific cells in
autoimmune diseases are typically low, which could be due to true sca
rcity or to limitations of in vitro assays. In the present study, anti
gens were targeted to the antigen-presenting cell (APC) to enhance T c
ell proliferation, using an antigen delivery system (ADS), consisting
of biotinylated anti-IgG, streptavidin and biotinylated antigen. This
was able to bind B cells and monocytes and was internalized within 24
hours. T cell proliferation to tetanus toroid was at least doubled usi
ng the ADS compared to conventional assay with antigen in simple solut
ion. To evaluate the ADS in an autoimmune disease, we determined T cel
l responses to the insulin-dependent diabetes mellitus (IDDM)-associat
ed autoantigen IA-2ic in patients with recent-onset IDDM. When IA-2ic
was available conventionally in solution, proliferation was poor, but
significantly higher in IDDM patients than control subjects. However,
the ADs significantly enhanced proliferation by a mean 3-fold for all
subjects, while maintaining the significant difference between IDDM pa
tients and healthy controls. Increases in T cell proliferation via the
ADS were due to the recruitment of approximately 3 times the number o
f CD4 + T cells stimulated in conventional assays. B cell depletion ab
olished enhancement suggesting that the ADS operates through recruitme
nt of B cells as APCs. This flexible modification of the T cell assay
offers greatly enhanced sensitivity for determining the frequency of a
ntigen and autoantigen-reactive T cells. (C) 1998 Published by Elsevie
r Science B.V. All rights reserved.